Gunma, Japan

Yasunori Yamaguchi


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasunori Yamaguchi: Innovator in Human Antigen-Presenting Cell Activation

Introduction

Yasunori Yamaguchi is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of immunology, particularly in the activation of human antigen-presenting cells. His innovative work has the potential to impact treatments for various diseases, including cancer and infectious diseases.

Latest Patents

Yamaguchi holds a patent for a method for activating human antigen-presenting cells, which is crucial for developing therapies for cancer and infectious diseases. The patent, titled "Method for activating human antigen-presenting cells, activated human antigen-presenting cells, and use thereof," describes a technique involving in vitro cultivation with specific glycoside compounds. This method allows for the activation of human-derived antigen-presenting cells without the need for tumor antigens, providing a promising avenue for therapeutic applications.

Career Highlights

Yasunori Yamaguchi is currently associated with Kirin Brewery Company, Limited, where he continues to advance his research. His work has garnered attention for its innovative approach to immunotherapy, particularly in enhancing the efficacy of treatments for serious health conditions.

Collaborations

Yamaguchi has collaborated with esteemed colleagues, including Yasuhiko Koezuka and Kazuhiro Motoki. These partnerships have contributed to the development and refinement of his groundbreaking research.

Conclusion

Yasunori Yamaguchi's contributions to the field of immunology through his patent on activating human antigen-presenting cells highlight his role as an influential inventor. His work promises to enhance therapeutic strategies for cancer and infectious diseases, showcasing the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…